arrow
L

Lucrezia Laterza

Università Cattolica del Sacro Cuore
H指数:22
被引数:2,072

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)

真实世界中乌帕替尼在克罗恩病患者中的有效性和安全性——一项来自意大利炎症性肠病研究组(IG-IBD)的多中心前瞻性研究

2026-09-110
PRE
IBD Nurse-Led Clinical Pathways to Optimize Patient Safety in Advanced Therapies: A Narrative Review

炎症性肠病护士主导的临床路径以优化先进疗法中的患者安全:一项叙事综述

2026-09-070
OAAI
Preoperative myopenia is associated with postoperative complications and endoscopic recurrence after ileocolic resection in Crohn’s disease

术前肌少症与克罗恩病回结肠切除术后并发症及内镜复发相关

2026-09-060
PRE
VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial

VSL#3® 可能在伴有肠易激综合征样症状的溃疡性结肠炎缓解期中减轻腹部疼痛和腹胀:一项探索性随机、双盲、安慰剂对照试验

2026-08-110
OA
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn’s disease: A real- world latium net study

维多珠单抗用于克罗恩病术后复发的预防和治疗:一项真实世界Latium网络研究

2026-05-300
OAAI
Determinants of Sarcopenia in Crohn's Disease: Effects of Short Bowel Syndrome and Protein Intake

克罗恩病中肌少症的决定因素:短肠综合征和蛋白质摄入的影响

2026-01-010
PRE
Long-term outcome of patients with Ulcerative Colitis after Ileal Pouch-Anal Anastomosis: the Latium NET study, preliminary data

溃疡性结肠炎患者行回肠储袋肛管吻合术后长期预后:拉齐奥NET研究,初步数据

2026-01-010
PRE
MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

MIRACLE-UC:溃疡性结肠炎患者真实世界临床及长期疗效与不良事件的米rikizumab调查评估——一项来自意大利炎症性肠病研究组(IG-IBD)的多中心前瞻性研究

2026-01-010
PRE
Patient-Physician mismatch in therapeutic targets for advanced therapy in inflammatory bowel disease patients: the PROMISE study

炎症性肠病患者先进疗法治疗目标的患者-医师匹配差异:PROMISE研究

2026-01-010
PRE
The Prognostic Impact of Sarcopenia on Surgical Outcomes and Postoperative Recurrence After Ileocolic Resection in Crohn's Disease

克罗恩病回结肠切除术后肌肉减少症对手术结果和术后复发的预测影响

2026-01-010
PRE
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium net

美瑞克zumab在溃疡性结肠炎中的有效性与安全性:拉齐奥网的真实世界数据

2026-01-010
PRE
Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity
2025-12-290
PRE
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn’s Disease: A Prospective Study

克罗恩病患者发生短肠综合征的临床预测因素:一项前瞻性研究

2025-09-090
OA
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial

多菌株益生菌联合维生素D可改善非便秘型肠易激综合征的肠道屏障功能和肠道微生物组成:一项双盲、随机、安慰剂对照试验的结果

2025-05-180
OA
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study

Vedolizumab在炎症性肠病中的真实世界结局及其机器学习预测——IG-IBD LIVE研究

2025-05-120
PRE